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Abstract
 
Control of the intracellular protozoan, 
 
Leishmania major
 
, requires major histocompatibility
complex class II (MHC II)–dependent antigen presentation and CD4
 
 
 
 T cell T helper cell 1
(Th1) differentiation. MHC II–positive macrophages are a primary target of infection and a
crucial effector cell controlling parasite growth, yet their function as antigen-presenting cells
remains controversial. Similarly, infected Langerhans cells (LCs) can prime interferon (IFN)
 
 
 
–
producing Th1 CD4
 
 
 
 T cells, but whether they are required for Th1 responses is unknown.
We explored the antigen-presenting cell requirement during primary 
 
L. major
 
 infection using a
mouse model in which MHC II, I-A
 
 
 
b
 
, expression is restricted to CD11b
 
 
 
 and CD8
 
 
 
 
 
 dendritic
cells (DCs). Importantly, B cells, macrophages, and LCs are all MHC II–negative in these
mice. We demonstrate that antigen presentation by these DC subsets is sufficient to control a
subcutaneous 
 
L. major
 
 infection. CD4
 
 
 
 T cells undergo complete Th1 differentiation with
parasite-specific secretion of IFN
 
 
 
. Macrophages produce inducible nitric oxide synthase,
accumulate at infected sites, and control parasite numbers in the absence of MHC II expression.
Therefore, CD11b
 
 
 
 and CD8
 
 
 
 
 
 DCs are not only key initiators of the primary response but
also provide all the necessary cognate interactions for CD4
 
 
 
 T cell Th1 effectors to control this
protozoan infection.
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Introduction
 
Leishmania major
 
 is an intracellular protozoan that infects
and multiplies within macrophages, although it can also
infect Langerhans cells (LCs), DCs, and neutrophils (1, 2).
Clearance of 
 
L. major
 
 in resistant C57Bl/6 mice requires
IL-12–driven Th1 CD4
 
 
 
 T cells and macrophage activa-
tion for the killing of intracellular amastigotes (2). This
immune regulation is MHC class II (MHC II)–dependent;
MHC II–positive B cells, macrophages, and DCs accumulate
in draining LNs of resistant mice (3) and class II–deficient
(A
 
 
 
b
 
   
 
) mice cannot control the infection (4). However,
the class II–positive APCs required for CD4
 
 
 
 T cell prim-
ing, effector differentiation, and parasite control have not
been identified.
MHC II
 
 
 
 DCs prime CD4
 
 
 
 Th1 cells to nominal antigens
(5) and could fulfill this role during 
 
L. major
 
 infection (1).
CD8
 
 
 
 
 
 and CD11b
 
 
 
 DCs can be infected in vitro (6), and
T cell priming to an immunodominant 
 
L. major
 
 peptide is
mediated by CD11b
 
 
 
 DCs (7). Transfer of 
 
L. major
 
–infected
LCs can also confer resistance to susceptible strains (8). The
DC subsets that initiate Th1 priming in vivo have not been
delineated clearly.
The local accumulation of MHC II
 
 
 
 infected macro-
phages and their role in parasite lysis suggest that these cells
are the central APC-mediating parasite control (3, 9). Pro-
duction of IL-12, TNF
 
 
 
, nitric oxide (NO), and IFN
 
 
 
 by
macrophages can contribute to Th1 polarization, effector
Th1 CD4
 
 
 
 T cell maintenance, and parasite lysis (9–11).
Macrophage secretion of these molecules can be facilitated
by MHC II peptide–TCR and CD40–CD40L interactions
(12, 13), but noncognate mechanisms such as Toll-like
receptor signaling, TNF
 
 
 
, and IFN
 
 
 
 also elicit cytokine
secretion and activation (14). Thus, the relative require-
ment of MHC II expression within different DC subsets
and macrophages has not been established.
To study the cognate interactions that mediate control of
 
L. major
 
, we took advantage of the CD11c/A
 
 
 
b
 
 transgenic
mouse model in which MHC II expression is restricted to
CD11b
 
 
 
 and CD8
 
 
 
 
 
 DCs (5). We report that CD11c/A
 
 
 
b
 
mice develop normal immunity to the intracellular parasite,
 
L. major
 
, and control this subcutaneous infection, indicating
that antigen presentation by CD11b
 
 
 
 and CD8
 
 
 
 
 
 DCs is
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sufficient for Th1 differentiation and effector functions
throughout the primary response.
 
Materials and Methods
 
Animals.
 
CD11c/A
 
 
 
b
 
 (5) and A
 
 
 
b
 
   
 
 mice were bred in our
colony (9 and 22 generations backcrossed to C57Bl/6). TCR
 
 
 
   
 
,
C57Bl/6, and B6.SJL (CD45.1) mice were obtained from Jackson
Laboratories. Mice 6–10 wk of age were used in all experiments.
 
Contact Sensitization and LC Isolation.
 
Mice were anesthe-
tized, shaved, and painted on the back with 30 
 
 
 
l FITC (Sigma-
Aldrich) diluted in 1:1 acetone/dibutyl acetate (Sigma-Aldrich)
as described previously (15). 18–24 h after application of FITC,
brachial, inguinal, and auricular LNs were digested at room tem-
perature in 0.8 mg/ml collagenase type IV (Worthington Bio-
chemicals) and 0.05% DNase I (Sigma-Aldrich) for 30–45 min.
CD11c
 
 
 
 cells were purified using CD11c MACS beads (Mil-
tenyi Biotech) on paramagnetic AUTOMACS columns according
to the manufacturer’s instructions. CD11c
 
 
 
 cell purity ranged
from 85 to 95%.
 
Flow Cytometry.
 
Single cell suspensions were blocked with
anti-FcRII/III (24G2; American Type Culture Collection).
Staining of APCs was performed in PBS with 2% BSA, 2 mM
EDTA, 1 
 
 
 
g/ml mouse IgG (Sigma-Aldrich), and 1 
 
 
 
g/ml rat
IgG (Sigma-Aldrich). All conjugated antibodies used for staining
were obtained from BD Biosciences. Intracellular staining was
performed on 1% PFA fixed samples, which were permeabilized
with 2% BSA and 0.02% saponin in PBS. For intracellular IFN
 
 
 
staining, LN cells were first stimulated with 50 ng/ml PMA and
500 ng/ml ionomycin in the presence of 2 nM monensin for 5 h
at 37
 
 
 
C. Samples were analyzed on a FACSCalibur™ (BD Bio-
sciences) using CELLQuest™ software. All dot plots have a log
axis of 10
 
0
 
–10
 
4
 
.
 
Polyclonal T Cell Purification.
 
B6.SJL spleen and LN suspen-
sions were incubated with supernatants of 24G2, RA3, M1/70,
and M5/114 (American Type Culture Collection) followed by
goat anti–rat IgG magnetic beads (Polysciences, Inc.) and cells
were removed by attaching to a magnetic stand (Bio-Mag; Poly-
sciences, Inc.).
 
L. major Infections and Analysis.
 
Purified CD45.1
 
 
 
 CD4
 
 
 
 T
cell suspensions were transferred i.v. into hosts. 1 d later, the hind
footpad was infected with 5 
 
 
 
 10
 
5
 
 stationary phase 
 
L. major
 
 pro-
mastigotes (MHOM/IL/80/Friedlin) grown in Grace’s media as
described previously (16). Footpad swelling was measured with a
digital caliper and reported as the difference between infected and
uninfected hind footpads. Standard deviation represents the dif-
ference in measurements within individual mice of the same ge-
notype. Mice with swelling 
 
 
 
5 mm were killed.
4, 7, or 9 wk after infection, infected footpads were processed
for parasite counts (16) or immunohistochemistry (5). Antibodies
GK1.5, M5/114, N418 (American Type Culture Collection), in-
ducible NO synthase (iNOS)–FITC, and IFN
 
 
 
 (BD Biosciences)
were used. FITC-stained slides were visualized on an IMT-2
fluorescence microscope (Olympus) and analyzed using SPOT
software (HiTech).
Splenic CD4
 
 
 
 T cells were purified using CD4 MACS beads
(Miltenyi Biotech) on AUTOMACS columns. C57BL/6 T-depleted
splenocytes were prepared by low-toxicity complement depletion
(Cedarlane) with anti-Thy1 (MMT1) antibodies. 10
 
6
 
 CD4
 
 
 
 T cells
were cultured with 5 
 
 
 
 10
 
6
 
 C57Bl/6 T-depleted splenocytes and
10 
 
 
 
g/ml soluble 
 
L. major
 
 antigen (16) for 3 d. Supernatants were
analyzed by sandwich ELISA for IFN
 
 
 
 production.
 
Results and Discussion
 
To test the sufficiency of CD11b
 
 
 
 and CD8
 
 
 
 
 
 DC anti-
gen presentation in control of 
 
L. major
 
 infection, we in-
fected CD11c/A
 
 
 
b
 
 mice. In CD11c/A
 
 
 
b
 
 mice, the CD11c
promoter reconstitutes A
 
 
 
b
 
 expression in B6 A
 
 
 
b
 
   
 
 mice
(5). CD8
 
 
 
 
 
 and CD11b
 
 
 
 DCs are class II positive, but
other DC subtypes, specifically plasmacytoid DCs and LCs
lack I-A
 
b
 
 expression (5). B cells, macrophages, and paren-
chymal cells are also MHC II negative (5). We used
CD11c/A
 
 
 
b
 
 mice to determine the role of different APCs
in the Th1 response to 
 
L. major
 
.
 
MHC II Expression in CD11c/A
 
 
 
b
 
 Mice.
 
First, we de-
termined whether APC subsets from CD11c/A
 
 
 
b
 
 mice
maintained their MHC II–negative phenotype after expo-
sure to inflammatory signals in vivo. LCs migrating out of
skin explants lacked MHC II expression in CD11c/A
 
 
 
b
 
mice (5). To examine LC expression during inflammation,
we painted the ears and dorsal skin of mice with FITC di-
luted in irritant. In response to the stimulus, FITC-painted
epidermal DCs migrated into the draining LNs, and were
detected within 16–48 h (reference 15 and unpublished
data). FITC-painted cells only migrated into skin-draining
LNs, indicating specific painting of LCs (unpublished data).
We analyzed FITC-negative and FITC-positive DCs in
skin-draining LNs for MHC II expression (Fig. 1 A).
FITC-painted LCs from A
 
 
 
b
 
   
 
 mice were MHC II bright;
whereas, FITC-painted LCs from CD11c/A
 
 
 
b
 
 mice re-
Figure 1. LCs, B cells, and macrophages lack MHC II expression in
CD11c/A 
b mice. (A) MHC II expression on LCs (CD11c  FITC ) or
resident LN DCs (CD11c  FITC ) obtained from the draining LNs of
mice after epidermal irritation (n   3 per genotype). (B–D) MHC II
levels on APCs harvested from draining LNs of mice infected with L.
major 4–7 wk earlier. (B) CD11b  CD11c  macrophages. (C) CD45R 
B cells. (D) CD11c  DCs. Histograms correspond to representative A 
b / 
(light gray with dashed line), CD11c/A 
b (black line), and A 
b /  (dark
gray) mice.Lemos et al. Brief Definitive Report 727
mained MHC II negative. In contrast, FITC-negative DCs
from A 
b    and CD11c/A 
b mice (including CD11b  and
CD8   cells) stained MHC II positive. Thus, CD11b  and
CD8   LN DCs from CD11c/A 
b mice, but not LCs, are
MHC II positive during inflammation.
To verify that MHC II expression in CD11c/A 
b mice
remained restricted to CD8   and CD11b  DCs during L.
major infection, we also examined APCs during infection.
4–7 wk after footpad infection, draining popliteal LNs of
A 
b    mice included MHC IIintermediate CD11b  and
CD8   populations, as well as LCs, identified previously as
MHC IIhigh (17). Popliteal LNs of infected CD11c/A 
b
mice also contained MHC IIintermediate populations, but
lacked the MHC IIhigh population of LCs (Fig. 1 D). In-
stead, draining LNs in CD11c/A 
b mice contained an
MHC IInegative population, suggesting that LCs lack MHC
II throughout this chronic infection.
Macrophages and B cells in the CD11c/A 
b mouse model
remain MHC II negative after in vitro exposure to IFN  or
LPS (5). Macrophages from L. major–infected A 
b    and
CD11c/A 
b mice also lacked surface MHC II, but A 
b   
macrophages were MHC II positive (Fig. 1 B). Similarly,
A 
b    B cells had MHC II expression; whereas, A 
b    and
CD11c/A 
b B cells were MHC II deficient (Fig. 1 C).
Finally, it was important to establish that MHC II expres-
sion at the site of infection mirrored that in the LNs. Diffuse
I-Ab staining was observed in A 
b    footpads, where MHC
II expression was present in macrophages, CD11c  DCs,
and parenchymal cells (Fig. 4 C and not depicted; reference
3). In contrast, CD11c/A 
b lesions had MHC II expression
limited to isolated CD11c  foci (Fig. 4 C and not depicted).
Thus, antigen presentation in CD11c/A 
b mice during L.
major infection is restricted to CD8   and CD11b  DCs
both in the LN and at the primary site of infection.
Control of L. major. CD11c/A 
b mice lack MHC II ex-
pression on cortical thymic epithelium and have no MHC
II–restricted CD4  T cells (5). However, adoptive transfers
of naive polyclonal CD4  T cells into SCID and RAG-defi-
cient mice restore control of L. major infections (18, 19).
Therefore, we transferred 15–20   106 polyclonal CD45.1 
T cells into A 
b   , A 
b   , or CD11c/A 
b mice 1 d before
infection. TCR     mice were also infected because they
have wild-type expression of I-Ab but, like CD11c/A 
b
mice, would depend on transferred cells for parasite control.
Mice were infected in the footpad with 5   105 stationary
phase promastigotes on day 1, and footpad swelling was
monitored weekly (Fig. 2 A). In A 
b    mice, lesion size
peaked at week 5 and resolved by week 8. In contrast, A 
b   
mice developed large nonhealing lesions requiring euthanasia
between weeks 6 and 9. Parasite titers were consistent with
lesion size (Fig. 2 B). Thus, control of parasite growth and
lesion resolution was MHC II dependent.
The disease courses in CD11c/A 
b and MHC II–positive
TCR     mice infected with L. major were similar. Mini-
mal swelling was detected throughout the infection, sug-
gesting a role for endogenous CD4  T cells in the develop-
ment of local inflammation (Fig. 2 A). However, CD4  T
cells transferred into CD11c/A 
b and TCR     mice–
mediated parasite control efficiently; parasite loads 9 wk af-
ter infection were comparable to those of A 
b    mice (Fig.
2 B). No footpad swelling was detected for 15 wk after in-
fection (unpublished data), so CD4  T cells control L. ma-
jor growth for an extended period rather than simply delay
the outgrowth of the parasite. Thus, MHC II–dependent
antigen presentation by CD11b  and CD8   DCs mediate
all the functions necessary for control of L. major.
L. major–dependent Th1 Differentiation. To examine
Th1 differentiation in response to L. major, IFN  produc-
tion was assayed. First, CD4 T cells from draining
(popliteal) or distant (cervical) LNs were harvested 4 or 9
wk after infection, and IFN  production was assayed after
restimulation with PMA and ionomycin (Fig. 3 A). Distant
cervical LNs served as a control for the absence of L. major–
specific responses. CD45.1  cells (right quadrants) are
transferred MHC II–restricted CD4  T cells; the CD45.1 
CD4  T cells are endogenous cells (left quadrants). A 
b   
mice have endogeneous MHC II–restricted CD4 T cells,
which produced most of the IFN  in the popliteal LNs.
However, more CD4 T cells in the popliteal LNs pro-
duced IFN  than at distant sites. In contrast, MHC II–
restricted transferred CD4  T cells did not accumulate in
Figure 2. CD8   and CD11b  DC antigen presentation is sufficient
for control of L. major lesions. (A) Footpad swelling in infected A 
b / ,
CD11c/A 
b, A 
b / , and A 
b /  TCR  /  mice that received CD45.1 
T cells before infection (n   5 mice/genotype). (B) Parasite load at 6–9 wk
after infection expressed as logarithm of parasite counts. Standard error of
4–7 mice/genotype is indicated. There was no difference in pathogen
clearance amongst CD11c/A 
b, A 
b / , and TCR  /  mice, but all had
significantly lower parasite loads than I-A 
b /  mice (P   0.002).Dendritic Cell Antigen Presentation Controls Leishmania major 728
the draining LNs of A 
b    mice (4–6% of the transferred
CD45.1  cells produced IFN  at this site, a proportion
comparable to the staining in the cervical LNs). Endoge-
nous MHC II–independent CD4  cells (probably NKT
cells) do accumulate at the site of infection in A 
b    mice,
but cannot control the pathogen (4, 20, 21).
CD11c/A 
b and TCR     mice, which lack endoge-
nous MHC II–restricted CD4  T cells, accumulated
CD45.1  CD4  T cells in the popliteal LNs, where 20–
35% of the transferred CD4 T cells produced IFN  (Fig. 3
A). The increased IFN  production was specific, as  3% of
the CD4  T cells in the cervical LNs produced this cyto-
kine. To confirm the antigen specificity of this Th1 re-
sponse, splenic CD4  T cells were purified and restimulated
in vitro for 3 d. IFN  in the supernatants was measured by
ELISA. Importantly, IFN  produced by CD4  T cells of
A 
b   , TCR    , and CD11c/A 
b mice was antigen spe-
cific and MHC II dependent (Fig. 3 B). Therefore, antigen
presentation by DCs is sufficient for the local expansion of
L. major–responsive MHC II–restricted CD4  Th1 cells.
We used immunohistochemistry to confirm that L. major–
specific Th1 cells migrated into the L. major–infected foot-
pad. Strikingly, CD4  T cells that secreted IFN  (not de-
picted) were present in the lesions of I-A 
b   , CD11c/A 
b,
and TCR     mice, but not in A 
b    footpads (Fig. 4 C).
The result indicated that DC-restricted MHC II expression
was sufficient for Th1 CD4  T cell differentiation, migra-
tion into infected sites, and effector function.
L. major–infected macrophages might not effectively
prime CD4  T cells, but they have been shown to enhance
Th1 polarization in vitro (22). The current data suggest
that any macrophage functions required for differentiation
of Th1 effectors must be noncognate, perhaps functioning
through TNF , iNOS, or IFN /  production (9–11).
Similarly, LCs are either not necessary for anti–L. major re-
sponses or they do not need to express MHC II to play a
role in Th1 immunity. However, it will be important to as-
sess the requirement for LC MHC II expression during in-
tradermal infection models, where LCs might be essential.
However, CD11b  and CD8   DC subsets without LC
or macrophage involvement are sufficient to mediate anti-
gen presentation and Th1 differentiation during subcutane-
ous L. major infection.
L. major–dependent Phagocyte Activation. Parasite con-
trol depends on activation of phagocytes (2). Thus, either
macrophage activation in CD11c/A 
b mice is noncognate,
or MHC class II–positive DCs can subsume functions nor-
mally attributed to macrophages. To analyze macrophage
activation, we examined CD40 up-regulation and iNOS
expression in macrophages harvested from popliteal LNs.
Macrophages accumulated in the draining LNs of A 
b   ,
CD11c/A 
b, and TCR     mice, but not I-A 
b    mice
(unpublished data). However, surface expression of CD40
staining was equivalent in all genotypes (Fig. 4 A). Thus,
CD40 expression is independent of either Th1 effectors or
cognate antigen presentation.
iNOS-dependent NO production also contributes to L.
major control (2). Expression of iNOS in popliteal LN mac-
rophages was only detectable in A 
b   , CD11c/A 
b, and
TCR     macrophages (Fig. 4 B). Macrophages in A 
b   
and TCR     mice contained more iNOS than those in
CD11c/A 
b mice (Fig. 4 B), suggesting a cognate compo-
nent to regulation of the enzyme, but this had no effect on
parasite loads at weeks 4, 7, and 9 (Fig. 2 B and not de-
picted). Immunofluorescence of the footpad revealed that
iNOS was also present in the infection site of A 
b   ,
CD11c/A 
b, and TCR    , but not A 
b    mice (Fig. 4
E). Thus, cognate macrophage–CD4 T cell interactions are
not required for either CD4  T cell recruitment to inflamed
tissues or macrophage activation and effector functions.
Figure 3. DCs mediate L. major–specific Th1 differentiation. (A) Intra-
cellular IFN  staining from CD4 T cells 9 wk after footpad infection.
Transferred CD45.1  cells and endogenous CD45.1  CD4  T cells are
depicted. (n   5–8 mice/genotype). Under each dot plot, the total number
of CD4  T cells recovered from the harvested LNs is shown. (B) IFN 
production from purified splenic CD4  T cells after 72 h of incubation
with the indicated APCs, in the presence or absence of soluble L. major
antigen (SLA). CD4  T cells from three mice of each genotype were
combined. This experiment is representative of three individual experiments.Lemos et al. Brief Definitive Report 729
One interpretation of our results is that IFN  production
by differentiated effector CD4  T cells at the site of infec-
tion is antigen dependent, and relies on CD11b  and
CD8   DCs. Indeed, we detected recruitment of CD11c 
cells to local sites of infection. Therefore, the role of DCs
in the primary immune response could extend beyond ini-
tiation of CD4  T cell responses to control CD4  T cell
functions during the effector phase. Alternatively, IFN  se-
cretion from activated CD4  T cells could occur in the ab-
sence of cognate antigen presentation in vivo. In this sce-
nario, MHC II–TCR interactions would be required for
priming, but activated effector CD4  T cells could secrete
IFN  without further TCR triggering. This would imply
that the effector cytokine delivery of the CD4  T cell re-
sponses might be less specific than previously thought.
Finally, control of L. major infection also requires phago-
cyte activation and the killing of intracellular amastigotes
(2). In CD11c/A 
b mice, MHC II–deficient macrophages
must respond to IFN  and/or CD40–CD40L interactions
without cognate T cell interactions. Thus, pathogen clear-
ance functions attributed to macrophages, such as NO pro-
duction, phagocytosis, and lysis of infectious organisms (9),
lack the specificity requirements of antigen presentation.
Our results imply that the immune system can avoid patho-
gens’ attempts to block antigen presentation within the in-
fected macrophage because antigen presentation by this cell
type is not a requirement for activation or parasite lysis.
In conclusion, we have demonstrated the sufficiency of
CD11b and CD8   DC antigen presentation in the initia-
tion and effector phases of Th1 immunity to L. major. Our
findings suggest that antigen presentation by macrophages,
keratinocytes, pDCs, and LCs are not required for either dif-
ferentiation of Th1 CD4  T cells responding to L. major or
the effector phases that follow. It will be interesting to deter-
mine if other APCs play a more important role in secondary
immune responses against L. major because memory CD4 
T cells survey tissues where resident L. major–infected mac-
rophages and LCs might be more important APCs.
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